Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15

Biology of Reproduction

Volumn 62, Issue 4, 2000, Pages 959-968

  Verma, Sanjay ^a   Hiby, Susan E ^a   Loke, Yung Wai ^a   King, Ashley ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2; MESSENGER RNA; PROGESTERONE; STEM CELL FACTOR;

ARTICLE; CELL PROLIFERATION; CELL STRAIN K 562; CHORIOCARCINOMA; CONTROLLED STUDY; CYTOLYSIS; DECIDUA; ENDOMETRIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOTHER FETUS RELATIONSHIP; NATURAL KILLER CELL; PLACENTA; PREGNANCY; PRIORITY JOURNAL; TROPHOBLAST;

EID: 0034062587     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod62.4.959     Document Type: Article

References (61)

1. King A, Balendran N, Wooding P, Carter NP, Loke YW. CD3 leukocytes present in the human uterus during early placentation: phenotypic and morphologic characterization of the CD56 population. Dev Immunol 1991; 1:169-190.
2. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum Reprod 1991; 6:791-798.
3. Nishikawa K, Saito S, Morii T, Hamada K, Ako H, Narita N, Ichijo M, Kurahayashi M, Sugamura K. Accumulation of CD16 CD56 natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua. Int Immunol 1991; 3:743-750.
4. King A, Wellings V, Gardner L, Loke YW. Immunocytochemical characterisation of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle. Hum Immunol 1989; 24: 195-205.
5. Bulmer JN, Johnson PM, Bulmer D. Leukocyte populations in human decidua and endometrium. In: Gill TJ, Wegmann TG (eds.), Immunoregulation and Fetal Survival. New York: Oxford University Press; 1987: 111-134.
6. Loke YW, King A. Human Implantation: Cell Biology and Immunology. Cambridge: Cambridge University Press; 1995.
7. Pace D, Morrison L, Bulmer JN. Proliferative activity in endometrial stromal granulocytes throughout the menstrual cycle and early pregnancy. J Clin Pathol 1989; 42:35-39.
8. Tabibzadeh S. Proliferative activity of lymphoid cells in human endometrium throughout the menstrual cycle. J Clin Endocrinol Metab 1990; 70:437-443.
9. King A, Wheeler R, Carter NP, Francis DP, Loke YW. The response of human decidual leukocytes to IL-2. Cell Immunol 1992; 140:409-421.
10. bright natural killer cells. Cell Immunol 1993; 152:605-613.
11. Starkey PM. Expression on cells of early human pregnancy decidua of the p75, IL-2, and p145, IL-4 receptor proteins. Immunology 1991; 73:64-70.
12. King A, Loke YW. Human trophoblast and JEG choriocarcinoma cells are sensitive to lysis by IL-2 stimulated decidual NK cells. Cell Immunol 1990; 129:435-448.
13. Parhar RS, Yagel S, Lala PK. PGE2-Mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leucocytes in the decidua with potential anti-trophoblast activity. Cell Immunol 1989; 120:61-74.
14. Jokhi PP, King A, Sharkey AM, Smith SK, Loke YW. Screening for cytokine mRNAs in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction (RT-PCR). J Immunol 1994; 153:4427-4435.
15. bright natural killer cells in the early pregnancy decidua. Int Immunol 1993; 5:559-563.
16. King A, Jokhi PP, Smith S, Sharkey AM, Loke YW. Screening for cytokine mRNA expression in purified human villous and extravillous trophoblast populations using the reverse-transcriptase polymerase chain reaction (RT-PCR). Cytokine 1995; 7:364-371.
17. Mrozek E, Anderson P, Caligiuri MA. Role of interleukin-15 in the development of human CD56 natural killer cells from CD34 hematopoietic progenitor cells. Blood 1996; 87:2632-2640.
18. c cord blood hematopoietic progenitor cells and from transduced severe combined immunodeficiency X1 bone marrow cells. Blood 1996; 88:3901-3909.
19. Leclereq G, Debacker V, de Smedt M, Plum J. Differential effects of interleukin-15 and interleukin-2 on differential of bipotential T/natural killer progenitor cells. J Exp Med 1996; 184:325-326.
20. Mingari MC, Ponte M, Betone S, Schiavetti F, Vitale C, Bellomo R, Moretta A, Moretta L. HLA class 1-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8 T cells. Proc Natl Acad Sci USA 1997; 95:1172-1177.
21. Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999; 17:19-49.
22. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994; 180:1395-1403.
23. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri MA. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J Clin Invest 1995; 96:2578-2582.
24. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 1994; 264:965-968.
25. Seder RA, Grabstein KH, Berzofsky JA, McDyer JF. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15. J Exp Med 1995; 182:1067-1077.
26. Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA. A lymphokine provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 1994; 91: 4935-4939.
27. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994; 13:2822-2830.
28. Kennedy MK, Park LS. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. J Clin Immunol 1996; 16:134-143.
29. King A, Gardner L, Loke YW. Co-stimulation of human decidual natural killer cells by interleukin-2 and stromal cells. Hum Reprod 1999; 14:656-663.
30. Burrows TD, King A, Loke YW. Expression of integrins by human trophoblast and different adhesion to laminin or fibronectin. Hum Reprod 1993; 8:475-484.
31. Chumbley G, Hawley S, Carter NP, Loke YW. Human extravillous trophoblast MHC class I expression is resistant to regulation by interferon-α. J Reprod Immunol 1991; 20:289-296.
32. Loke YW, Hsi B-L, Bulmer JN, Grivaux C, Hawley S, Gardner L, King A, Carter NP. Evaluation of a monoclonal antibody, BC-1, which identifies an antigen expressed on the surface membrane of human extravillous trophoblast. Am J Reprod Immunol 1992; 27:77-78.
33. Gong JH, Maki G, Klingemann HG. Characterisation of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 1994; 8:652-658.
34. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 1996; 24:406-415.
35. Chumbley G, King A, Robertson K, Holmes N, Loke YW. Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell Immunol 1994; 155:312-322.
36. Verma S, King A, Loke YW. Expression of killer-cell inhibitory receptors (KIR) on human uterine NK cells. Eur J Immunol 1997; 27: 979-983.
37. Aramburu J, Balboa MA, Ramirez A, Silva A, Acevedo A, Sanchez-Madrid F, De Landazuri MO, Lopez-Botet M. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-γ/β T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody. J Immunol 1990; 144: 3238-3247.
38. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997; 186:1809-1818.
39. Hiby SE, King A, Sharkey AM, Loke YW. Human uterine NK cells have a similar repertoire of killer inhibitory and activatory receptors to those found in blood, as demonstrated by RT-PCR and sequencing. Mol Immunol 1997; 34:419-430.
40. Chomsezynski P, Sacchi E. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
41. King A, Birkby C, Loke YW. Early human decidual cells exhibit NK activity against K562 cell line but not against first trimester trophoblast. Cell Immunol 1989; 118:337-344.
42. Meazza R, Gaggero A, Neglia F, Basso S, Sforzini S, Pereno R, Azzarone B, Ferrini S. Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides. Eur J Immunol 1997; 27:1049-1054.
43. Gaggero A, Azzarone B, Andrei C, Mishal Z, Meazza R, Zappia E, Rubartelli A, Ferrini S. Differential intracellular trafficking, secretion and endosomal localization of two IL-15 isoforms. Eur J Immunol 1999; 29:1265-1274.
44. Anderson DM, Kumaki S, Ahdieh M, Bertles J, Tometsko M, Loomis A, Giri J, Copeland NG, Gilbert DJ, Jenkins NA, Valentine V, Shapiro DN, Morris SW, Park LS, Cosman D. Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15Rα and IL2Rα genes. J Biol Chem 1995; 270:29862-29869.
45. Giri JG, Anderson DM, Kumaki S, Park LS, Grabstein KH, Cosman D. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leukocyte Biol 1995; 57:763-766.
46. +dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis. Blood 1996; 88:2279-2287.
47. Sharkey AM, Jokhi PP, King A, Loke YW, Brown KD, Smith SK. Expression of c-kit and kit ligand at the human materno-fetal interface. Cytokines 1994; 6:195-205.
48. Kauma S, Huff T, Krystal G, Ryan J, Takacs P, Turner T. The expression of stem cell factor and its receptor, c-kit, in human endometrium and placental tissues during pregnancy. J Clin Endocrinol Metab 1996; 81:1261-1268.
49. Matos ME, Schnier GS, Beecher MS, Ashman LK, William DE, Caligiuri MA. Expression of a functional c-kit receptor on a subset of natural killer cells. J Exp Med 1993; 178:1079-1084.
50. bright natural killer cells mediated by increased expression of the IL-2 receptor alpha chain. J Reprod Immunol 1998; 40:1-24.
51. bright natural killer cell subsets: characterisation of distinct functional responses to interleukin-2 and the c-kit ligand. Eur J Immunol 1997; 27:354-360.
52. Escribano L, Ocqueteau M, Almeida J, Orfao A, San-Miguel JF. Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Leuk Lymphoma 1998; 30:459-466.
53. Carayol G, Robin C, Bourhis JH, Bennaceur-Griscelli A, Chouaib S, Coulombel L, Caignard A. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions. Eur J Immunol 1998; 28:1991-2002.
54. Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro E, Augugliaro R, Moretta L, Moretta A. NKp44 novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 1998; 15:2065-2072.
55. Sivori S, Pende D, Bottino C, Marcenaro E, Pessino A, Biassoni R, Moretta L, Moretta A. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol 1999; 29:1656-1666.
56. Loubeau M, Ahmad A, Toma E, Menezes J. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15. J Acquired Immune Defic Syndr Hum Retrovirol 1997; 16:137-145.
57. Flamand L, Stefanescu I, Menezes J. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 1996; 97:1373-1381.
58. Atedzoe BN, Ahmad A, Menezes J. Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. J Immunol 1997; 159:4966-4972.
59. Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA. The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. J Clin Invest 1994; 91:7553-7557.
60. Bulfone-Paus S, Ungureanu D, Pohl T, Lindner G, Paus R, Rückert R, Krause H, Kunzendorf U. Interleukin-15 protects from lethal apoptosis in vivo. Nat Med 1997; 3:1124-1128.
61. Ye W, Zheng L-M, Young JD-E, Liu C-C. The involvement of interleukin (IL)-15 in regulating the differentiation of granulated metrial gland cells in mouse pregnant uterus. J Exp Med 1996; 184:2405-2410.